• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
RACGP calls for improved resources for tick-borne diseases

RACGP calls for improved resources for tick-borne diseases

As part of a Senate investigation into the illnesses, the college says GPs must be equipped with clear and evidence-based information.


Live from GP24: Understanding inflammatory bowel disease

Live from GP24: Understanding inflammatory bowel disease

Recorded live at GP24 in Perth, host Dr Tim Koh talks with Dr Luca Crostella, an experienced gastroenterologist, about the diagnosis of inflammatory bowel disease.


‘Promising’ new statistical tool predicts dementia onset

‘Promising’ new statistical tool predicts dementia onset

Early research shows the model can predict onset more accurately than similar tools, with hopes it will give patients more time to make decisions.


Japanese encephalitis virus spreads to new areas

Japanese encephalitis virus spreads to new areas

With the virus detected in NSW and Victoria and the season’s first human case, GPs should be prepared for patients asking about protection.


Should Australia be worried about HMPV?

Should Australia be worried about HMPV?

As cases of human metapneumovirus surge overseas, what do Australian GPs need to know when concerned patients walk through their door?


Arthritis rising among working-age patients: Study

Arthritis rising among working-age patients: Study

With diagnoses to jump by 31% in 15 years, experts say investment is needed before the disease impacts ‘productivity at a national level’.


Australia’s new leading contributor to burden of disease

Australia’s new leading contributor to burden of disease

Smoking tobacco has been overtaken by overweight and obesity as the leading modifiable risk factor, according to a new report.


‘An excellent change’: Dapagliflozin PBS access expanded

‘An excellent change’: Dapagliflozin PBS access expanded

The shift to increase access to more type 2 diabetes patients is in line with RACGP recommendations and clinical guidelines.  


GLP-1 receptor agonists linked to kidney failure prevention: Study

GLP-1 receptor agonists linked to kidney failure prevention: Study

It found the diabetes and weight-loss drugs can reduce deterioration regardless of diabetes status, but supply remains an issue.


Hypertension costing Australia $1.2 billion a year

Hypertension costing Australia $1.2 billion a year

Researchers are calling for overhauled policies to reduce treatment costs and increase care access, with pharmacy fees making up 51% of spending.


  • Previous
  • 1
  • 2
  • 3
  • ...
  • Next
Pages: 2 of 34
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807